Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model.
Barberis, C., Erdman, P., Czekaj, M., Fire, L., Pribish, J., Tserlin, E., Maniar, S., Batchelor, J.D., Liu, J., Patel, V.F., Hebert, A., Levit, M., Wang, A., Sun, F., Huang, S.A.(2020) Bioorg Med Chem Lett 30: 127625-127625
- PubMed: 33096160 
- DOI: https://doi.org/10.1016/j.bmcl.2020.127625
- Primary Citation of Related Structures:  
6VRU, 6VRV - PubMed Abstract: 
N-substituted azaindoles were discovered as potent pan-PIM inhibitors. Lead optimization, guided by structure and focused on physico-chemical properties allowed us to solve inherent hERG and permeability liabilities, and provided compound 27, which subsequently impacted KG-1 tumor growth in a mouse model.
Organizational Affiliation: 
IDD Medicinal Chemistry, Sanofi, 153 Second Avenue, Waltham MA 02451, United States. Electronic address: claude.barberis2@sanofi.com.